19 results
PRE 14A
VRNA
Verona Pharma Plc
8 Mar 24
Preliminary proxy
4:18pm
LEADERSHIP STRUCTURE AND ROLE IN RISK OVERSIGHT
PERIODIC BOARD EVALUATION
CODE OF BUSINESS CONDUCT AND ETHICS
ANTI-HEDGING POLICY
ATTENDANCE … concerning any amendments to, or waivers from, any provision of the Code of Business Conduct and Ethics.
ANTI-HEDGING POLICY
Our Board of Directors has
424B5
n61n8su
11 Aug 22
Prospectus supplement for primary offering
5:09pm
424B5
osbdso5j46h7h0p5m811
9 Aug 22
Prospectus supplement for primary offering
12:00am
POS AM
dzfj5wwt
19 Mar 21
Prospectus update (post-effective amendment)
4:56pm
DEF 14A
zpyof n0s5w
19 Mar 21
Definitive proxy
4:02pm
10-K
4a1 g0th7wftf3rad0q
25 Feb 21
Annual report
8:29am
F-1/A
e0g62o
25 Aug 20
Registration statement (foreign) (amended)
4:06pm
F-1
wk4kcy6g ci
17 Aug 20
Registration statement (foreign)
6:41am
20-F
m8eeuzcejbaur2icw29
27 Feb 18
Annual report (foreign)
12:00am
- Prev
- 1
- Next